first commit

This commit is contained in:
libroot 2026-11-19 04:39:11 +02:00
commit 0d90363116
Signed by: libroot
GPG key ID: 2AC68C029EBE9ACE
6510 changed files with 679146 additions and 0 deletions

View file

@ -0,0 +1,39 @@
UNCLASSIFIED//FOR OFFICIAL USE ONLY
18 APRIL 2013
# Special Source Operations Weekly
UNCLASSIFIED//FOR OFFICIAL USE ONLY
---
UNCLASSIFIED//FOR OFFICIAL USE ONLY
The overall classification of this briefing is:
TOP SECRET//SI//ORCON/NOFORN
Approval for dissemination of information
contained in this briefing,
in whole or in part, is required.
DERIVED FROM: NSA/CSSM 1-52
DATED: 20070108
DECLASSIFY ON: 20360901
UNCLASSIFIED//FOR OFFICIAL USE ONLY
---
TOP SECRET//SI//NOFORN
## (TS//SI//NF) PRISM Reporting Highlight
### Insight provided into Iranian CBW-related Research
* Between January and March 2013, S2G12's Iran Chemical and Biological Warfare (CBW) team issued five sole-source (PRISM) reports
* Consisted of scientific research papers detailing activities conducted at Iran's Tehran University of Medical Sciences and Baghyatollah Medical Sciences University
* Both universities, which are suspected of being linked to Iranian CBW programs
* Highlighting Iran's human trials research involving patients exposed to organophosphorous (OP) compounds in pesticides and development of treatment creams
* Could also be used in the event of OP nerve agent exposure.
TOP SECRET//SI//NOFORN
(TS//SI//REL TO USA, FVEY) Between January and March 2013, S2G12's Iran Chemical and Biological Warfare (CBW) team issued 5 reports, all sole-sourced to FAA traffic, which consisted of scientific research papers detailing activities conducted at Iran's Tehran University of Medical Sciences and Baghyatollah Medical Sciences University. Reporting on these two universities, which are suspected of being linked to Iranian CBW programs, highlighted Iran's human trials research involving patients exposed to organophosphorous (OP) compounds in pesticides and development of treatment creams - research activities that could also be used in the event of OP nerve agent exposure. This type of information enabled IC customers, such as NCMI(National Center for Medical Intelligence) and NGIC(National Ground Intelligence Center), to assess the types of medical countermeasures being developed by Iran, as well as Iran's ability to respond to and protect against CBW threats. (Based on 3/00/501828-13, 3/00/505615-13, 3/00/507257-13, 3/00/507263-13, and 3/00/507268-13.)

View file

@ -0,0 +1,43 @@
{
"title": "Special Source Operations Weekly – 18 April 2013",
"type": "REPORTED",
"description": "",
"long_description": "",
"tags": [],
"document": {
"creator": "NSA",
"date_created": "2013-04-18",
"classification": [
"TOP SECRET",
"SI"
],
"dissemination": [
"NOFORN"
],
"banner": "TOP SECRET//SI//NOFORN",
"genre": "slides",
"programs": [
"PRISM",
"SSO"
],
"countries": [
"Iran"
],
"people": []
},
"publication": [
{
"publisher": "The Intercept",
"date_published": "2016-08-10",
"title": "How the U.S. Spies on Medical Nonprofits and Health Defenses Worldwide",
"link": "https://theintercept.com/2016/08/10/how-the-u-s-spies-on-medical-nonprofits-and-health-defenses-worldwide/",
"reporters": [
"McLaughlin, Jenna"
],
"contributors": [],
"doc_url": "https://s3.documentcloud.org/documents/3009449/NCMI-Pages-U18April2013-SSO-WeeklyBrief-v1-0.pdf"
}
],
"pdf_sha256": "df03ba2cfe8bc0498d447f3b9313eb64078cf2aff5d36a0385c5fc003db83995",
"pages": 3
}